BTAI
BioXcel Therapeutics, Inc. Common Stock
$1.90
2.15%
+0.04
Notify me if price changes either direction
Buy BTAI stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
38.2M
Enterprise value
119.2M
Trailing PE
-0.080816673755849
Forward PE
-1.1445783
PEG Ratio
0.0029840002617544
Enterprise to EBITDA
-2.391
Enterprise to revenue
137.285
Price to book MRQ
-0.13840545385308
Price to sales TTM
43.00567
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-06-30
Revenue (TTM)
868.0K
EBITDA
-49847000
Diluted EPS TTM
-11.9
Total Cash (MRQ)
17.4M
Current ratio (MRQ)
0.756
Operating Cash Flow (TTM)
-55765000
BTAI trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
November 2025
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
